Dr. Charles Grob

“Intention is critical to outcome. What we found in the 60’s was when someone had an intention taking a psychedelic to go out and have a good time to have a recreational experience that’s likely all they got.”

Medical Doctor
University of California Los Angeles School of Medicine
Director of the Division of Child and Adolescent Psychiatry at Harbor UCLA Medical Center

Charles S. Grob, M.D., is Professor of Psychiatry and Pediatrics at the UCLA School of Medicine and Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center. He conducted the first government-approved study of MDMA, and was the principal investigator of an international biomedical psychiatric research project in the Brazilian Amazon of the plant, ayahuasca. He is currently conducting an investigation of the effects of psilocybin on anxiety in cancer patients. Dr. Grob has published numerous articles in medical and psychiatric journals and collected volumes, and is the editor of Hallucinogens: A Reader. He is a founding board member of the Heffter Research Institute.

Dr. Grob recently co-edited, with Roger Walsh, "Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics", SUNY Press (State University of New York press), 2005.